The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Acer Therapeutics Inc | Common | 00444P108 | 14,071 | 579,051 | SH | SOLE | 579,051 | 0 | 0 | ||
Aclaris Therapeutics, Inc. | Common | 00461U105 | 9,867 | 1,647,214 | SH | SOLE | 1,647,214 | 0 | 0 | ||
Agile Therapeutics, Inc. | Common | 00847L100 | 2,286 | 1,513,975 | SH | SOLE | 1,513,975 | 0 | 0 | ||
Akari Therapeutics Plc | ADR | 00972G108 | 1,238 | 345,850 | SH | SOLE | 345,850 | 0 | 0 | ||
Amyris, Inc | Common | 03236M200 | 11,653 | 5,575,785 | SH | SOLE | 5,575,785 | 0 | 0 | ||
Apellis Pharmaceuticals, Inc. | Common | 03753U106 | 7,479 | 383,538 | SH | SOLE | 383,538 | 0 | 0 | ||
Arrowhead Pharmaceuticals Inc | Common | 04280A100 | 42,728 | 2,328,475 | SH | SOLE | 2,328,475 | 0 | 0 | ||
Ascendis Pharma A/S | ADR | 04351P101 | 240,912 | 2,046,832 | SH | SOLE | 2,046,832 | 0 | 0 | ||
Aurinia Pharmaceuticals Inc. | Common | 05156V102 | 7,886 | 1,213,290 | SH | SOLE | 1,213,290 | 0 | 0 | ||
Biohaven Pharmaceutical Holding Company Ltd | Common | G11196105 | 25,991 | 504,980 | SH | SOLE | 504,980 | 0 | 0 | ||
BioPharmX Corporation | Common | 09072X101 | 1,419 | 16,128,515 | SH | SOLE | 16,128,515 | 0 | 0 | ||
Codexis, Inc | Common | 192005106 | 53,767 | 2,618,951 | SH | SOLE | 2,618,951 | 0 | 0 | ||
Crinetics Pharmaceuticals Inc | Common | 22663K107 | 76,819 | 3,375,169 | SH | SOLE | 3,375,169 | 0 | 0 | ||
Cymabay Therapeutics Inc | Common | 23257D103 | 27,304 | 2,056,000 | SH | SOLE | 2,056,000 | 0 | 0 | ||
DBV Technologies S.A. | ADR | 23306J101 | 2,082 | 269,995 | SH | SOLE | 269,995 | 0 | 0 | ||
Dermira Inc | Common | 24983L104 | 9,485 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
Eiger BioPharmaceuticals Inc | Common | 28249U105 | 25,042 | 1,791,257 | SH | SOLE | 1,791,257 | 0 | 0 | ||
Galmed Pharmaceuticals Ltd | SHS | M47238106 | 7,936 | 971,337 | SH | SOLE | 971,337 | 0 | 0 | ||
Genocea Biosciences Inc | Common | 372427104 | 4,609 | 7,811,206 | SH | SOLE | 7,811,206 | 0 | 0 | ||
Homology Medicines, Inc. | Common | 438083107 | 32,160 | 1,159,742 | SH | SOLE | 1,159,742 | 0 | 0 | ||
Insmed Inc | Common Par | 457669307 | 34,020 | 1,170,290 | SH | SOLE | 1,170,290 | 0 | 0 | ||
Iovance Biotherapeutics, Inc. | Common | 462260100 | 15,216 | 1,600,000 | SH | SOLE | 1,600,000 | 0 | 0 | ||
Kadmon Holdings Inc | Common | 48283N106 | 33,281 | 12,606,605 | SH | SOLE | 12,606,605 | 0 | 0 | ||
Kala Pharmaceuticals, Inc. | Common | 483119103 | 8,626 | 1,043,020 | SH | SOLE | 1,043,020 | 0 | 0 | ||
KalVista Pharmaceuticals Inc. | Common | 483497103 | 38,899 | 1,359,149 | SH | SOLE | 1,359,149 | 0 | 0 | ||
Kiniksa Pharmaceuticals | Common | G5269C101 | 15,233 | 843,478 | SH | SOLE | 843,478 | 0 | 0 | ||
Matinas Biopharma Hldgs Inc | Common | 576810105 | 7,432 | 6,818,181 | SH | SOLE | 6,818,181 | 0 | 0 | ||
MEI Pharma Inc | Common | 55279B202 | 17,739 | 5,778,106 | SH | SOLE | 5,778,106 | 0 | 0 | ||
Menlo Therapeutics Inc. | Common | 586858102 | 31,488 | 4,011,236 | SH | SOLE | 4,011,236 | 0 | 0 | ||
Mirati Therapeutics Inc. | Common | 60468T105 | 18,406 | 251,107 | SH | SOLE | 251,107 | 0 | 0 | ||
Nabriva Therapeutics AG | SHS | G63637105 | 10,745 | 4,403,687 | SH | SOLE | 4,403,687 | 0 | 0 | ||
Obseva SA | Common | H5861P103 | 11,986 | 937,147 | SH | SOLE | 937,147 | 0 | 0 | ||
Orchard Therapeutics plc | ADS | 68570P101 | 8,611 | 481,609 | SH | SOLE | 481,609 | 0 | 0 | ||
Precision Biosciences Inc | Common | 74019P108 | 5,035 | 280,511 | SH | SOLE | 280,511 | 0 | 0 | ||
Selecta Biosciences Inc | Common | 816212104 | 1,289 | 546,054 | SH | SOLE | 546,054 | 0 | 0 | ||
Sierra Oncology, Inc | Common | 82640U107 | 4,169 | 2,438,270 | SH | SOLE | 2,438,270 | 0 | 0 | ||
Sinovac Biotech Ltd. | SHS | P8696W104 | 38,173 | 5,900,000 | SH | SOLE | 5,900,000 | 0 | 0 | ||
Soleno Therapeutics, Inc. | Common | 834203200 | 8,981 | 4,359,683 | SH | SOLE | 4,359,683 | 0 | 0 | ||
Soleno Therapeutics, Inc. - Warrant | Warrant | 834203135 | 28 | 188,772 | SH | SOLE | 188,772 | 0 | 0 | ||
Strongbridge Biopharma plc | SHS USD | G85347105 | 4,552 | 914,062 | SH | SOLE | 914,062 | 0 | 0 | ||
Sunesis Pharmaceuticals, Inc. | Common Par | 867328700 | 121 | 99,441 | SH | SOLE | 99,441 | 0 | 0 | ||
Trevena, Inc. | Common | 89532E109 | 1,925 | 1,233,677 | SH | SOLE | 1,233,677 | 0 | 0 | ||
Tricida, Inc. | Common | 89610F101 | 29,529 | 781,185 | SH | SOLE | 781,185 | 0 | 0 | ||
Uniqure NV | Common | N90064101 | 10,757 | 180,336 | SH | SOLE | 180,336 | 0 | 0 | ||
Verona Pharma PLC | ADS | 925050106 | 9,704 | 1,492,951 | SH | SOLE | 1,492,951 | 0 | 0 | ||
Xenon Pharmaceuticals Inc | Common | 98420N105 | 14,280 | 1,405,476 | SH | SOLE | 1,405,476 | 0 | 0 | ||
Zai Lab Limited | ADR | 98887Q104 | 2,113 | 71,595 | SH | SOLE | 71,595 | 0 | 0 | ||
Zogenix Inc | Common | 98978L204 | 5,776 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
Zymeworks Inc | Common | 98985W102 | 10,034 | 620,134 | SH | SOLE | 620,134 | 0 | 0 |